Latest News

Dr. Sarah Stevens, former VP of Drug Development Sciences at Quotient Sciences, discusses the recent acquisition of Arcinova and the integration of drug substance, drug product, and clinical testing capabilities in a Drug ...

Quotient has been recognized with multiple 2021 CRO Leadership Awards, including two Champion Awards. The CRO Leadership Awards recognizes top performing outsourcing organizations in the drug development arena. Quotient received leadership ...

Dr. Sarah Stevens, former Vice President of Drug Development Sciences at Quotient Sciences, discusses our integrated approach to accelerating the development of poorly soluble compounds in a Drug Development & Delivery Spec...

Quotient Sciences announced that it has acquired Arcinova, a U.K.-based multiservice contract development and manufacturing organization (CDMO).

Quotient Sciences (formerly Arcinova) has recently taken delivery and commissioned the award-winning R1000 Robotic Capsule Filler from life-sciences automation company 3P Innovation. Technology investments increase the UK’s capacit...